UK equities
10 May 2018 | By Richard Buxton

Unloved opportunities for the patient investor

M&A activity may be intensifying in the UK stock market but valuations would suggest that investors are not overly exuberant, says Richard Buxton

  601 viewed

News that according to the Bank of America Merrill Lynch global fund manager survey, global investors have never been so underweight UK equities comes as little surprise to this investor, given that the UK All Companies sector has seen persistent outflows of money for four years.

It may be the impression that the UK economy is set to be one of the slowest growing now that Europe is recovering and the United States is benefiting from fiscal stimulus. It may be a concern that the UK will suffer materially post-Brexit or the probability that at some point Britain votes in a redistributive and anti-business government set to raise corporate tax rates.

Or, more constructively, it may be that domestic investors are at last recognising the degree to which they are under-exposed to US equities and addressing this in part through investing more in global equities.  Maybe the concern that this post-financial crisis economic recovery is long in the tooth – and the accompanying bull market is similarly aged – is encouraging investors to bank profits.

But whatever the reason, it is clear that UK large cap stocks are pretty unloved right now.

It is interesting, though, to note that this view appears to be at odds with the attractions that numerous corporates and activists can see in some UK shares. There are two bidders battling to win control of Sky, whilst Shire has just agreed a combination with Japan’s Takeda Pharmaceutical. Midcap engineer Fenner has agreed to be bought by France’s Michelin.

Meanwhile, activist investors have appeared on the share register of no fewer than three stocks I hold: Barclays, Micro Focus and Whitbread. These multi-million pound investments have not been undertaken lightly and point to significant undervaluation of these companies in the eyes of the activists.

For all that the bull market may be nine years old, it has certainly not reached extremes of valuation. With the FTSE All-Share index trading below its long-term average, at a little over 13 times forecast price/earnings multiple and a yield in excess of 4%, this would hardly suggest that investor euphoria is at a peak[1].

It is true that the scale of M&A activity globally is reaching levels that have the contrarian feeling nervous.  Deals are rarely done at bear market lows when bargains are available – as bidders themselves feel cautious and lack highly-valued equity with which to acquire. It is when confidence and share prices are high that the siren voices of investment banking advisors become irresistible to many boardrooms.

So a note of caution from the flurry of deal-making currently underway, but with an eye firmly on valuations the ground seems reasonably sound underfoot.

Investors often shun UK large cap stocks as they perceive that mature, low growth companies or industries such as banking or commodities can only offer low returns. But whilst there may be an element of truth to this, fortunately even in very large companies the stockmarket can let share prices fall far away from the intrinsic value of a business. You need to be patient and play a long game, but this does allow the investor to make considerable gains even in very large companies. 

Two years ago, HSBC shares were trading not much above 400p, yielding over 7.5%[2]. Some brokers were forecasting a dividend cut, which to our analysis looked completely unrealistic. Sure enough, once the bank repatriated some capital from the US and started buying back shares, the market took comfort that the dividend was sustainable and the shares rose to almost 800p[3].

Almost a doubling. From one of the UK’s biggest companies.

In 2015, against a background of falling oil prices BP shares fell almost to their lows of the immediate aftermath of the Macondo disaster in 2010[4].333p was the lowest price I paid for them in the fund. As I write, the shares have risen by two-thirds[5].

But you have to take a multi-year view and be patient. The chart below shows the long-term price of Tesco.  Many unitholders know I sold my holding in Tesco in May 2010 at 425p, concerned over their expansion into the US.  Several profit warnings, an accounting scandal, withdrawal from the US and a change of management later, I started to buy them back in 2015.

New management fully expected to take five years turning the business around. The market was persistently sceptical, enabling me to add to the holding as recently as a year ago at 178p[6]. And it is only now, into the fourth year of their tenure, that the market appears to believe that they can actually reach their goals, judging by the reaction to the most recent set of results.

So UK economic growth may be subdued, the bull market may be ageing, but UK equity valuations are not stretched and the market will continue to provide opportunities for the patient investor, even in UK large cap stocks.


[1] Source: Bloomberg, 12 month rolling forecasts for end December 2018.

[2] Source: Bloomberg as at 07 April 2016.

[3] Source: Bloomberg as at 11 January 2018.

[4] Source: Bloomberg as at 28 September 2015.

[5] Source: Bloomberg as at 08 May 2018.

[6] Source: Bloomberg as at 27 April 2017.

Next article:
Unloved opportunities for the patient investor

10 May 2018 | By Richard Buxton

M&A activity may be intensifying in the UK stock market but valuations would suggest that investors are not overly exuberant, says Richard Buxton

Read More
06 Nov 2020 | By Richard Watts
The Dynamic and Diverse Universe of UK Midcaps

UK mid caps are a dynamic part of the market offering a tremendous range of stock picking. Richard Watts, Head of Strategy, UK Small & Mid Cap, exp...

08 Jul 2020 | By Richard Buxton
Sunak’s Summer Statement: helpful, but is it enough?

Businesses and the economy will need all the help they can get as we emerge from lockdown; will today’s measures move the dial?